Dengue Vaccine In The Works, Phase-3 Trial Soon: Top Medical Body
NDTV
The vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR).
The phase-3 trial for a dengue vaccine developed by Panacea Biotech is likely to begin in a few months, a senior official said as quoted by news agency ANI.
The vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR).
The phase-3 trial is a randomised, double-blind, placebo-controlled trial. This means that participants are randomly assigned to receive either the vaccine or a placebo. Neither the participants nor the investigators will know who is receiving the vaccine and who is receiving the placebo.
"The trials are underway but they have not yet fully started because we are waiting for the company to make the product which could not be made three months ago. The company should be ready in August. So, those phase-3 trials should be initiated in a few months," said Dr Rajiv Bahl, director general of ICMR, as quoted by news agency ANI.